Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 1, 2002, Pages 58-62

  Maw, R D ^a   Kinghorn, G R ^b   Bowman, C A ^c   Goh, B T ^d   Nayagam, A T ^e   Nathan, M ^f  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e UK   (United Kingdom)

^f HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

External genital warts; Imiquimod; Immune response modifier; Treatment; Uncircumcised

Indexed keywords

IMIQUIMOD;

ADOLESCENT; ADULT; ARTICLE; CIRCUMCISION; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ERYTHEMA; HUMAN; MALE; PREPUCE; PRIORITY JOURNAL; UNITED KINGDOM; VERRUCA VULGARIS; WART VIRUS;

ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; HUMANS; INTERFERON INDUCERS; MALE; MIDDLE AGED; OINTMENTS; PENILE DISEASES; TREATMENT OUTCOME;

EID: 0036190229     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00366.x     Document Type: Article

References (19)

1. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel
2. New cases seen at genito urinary medicine clinics: England 1997
3. Human papillomavirus infection and genital warts: Update on epidemiology and treatment
4. Therapeutic approaches to genital warts
5. Latent papillomavirus and recurring genital warts
6. The role of the immune system in anogenital human papillomavirus
7. Immunological events in regressing genital warts
8. Imiquimod applied topically: A novel immune response modifier and new class of drug
9. Self-administered topical 5% imiquimod cream for external anogenital warts
10. 2 laser ablation
11. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
12. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine
13. Safety and efficacy of imiquimod 5% cream in the treatment of penile warts in uncircumcised men when applied three times weekly or once per day
14. Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic
15. Circumcision and sexually transmissible disease
16. Penile condylomata acuminata: An experimental model for evaluation of topical self-treatment with 0.5-1.0% ethanolic preparations of podophyllotoxin for three days
17. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
18. UK national guidelines for the management of anogenital warts
19. European course on HPV-associated pathology: Guidelines for the diagnosis and management of anogenital warts